Review



plenti tre3g be3ra pgk puro  (Addgene inc)


Bioz Verified Symbol Addgene inc is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 93
      Buy from Supplier

    Structured Review

    Addgene inc plenti tre3g be3ra pgk puro
    A .Optimized CASPROTAC 6 degraded dCas9 proteins. 293T-Tet-On 3G cells with stable integration of dCas9-APEX2 were pretreated with doxycycline (500 ng/mL) for 9 h to the simultaneous expression of Cas9-APEX2 protein complex, 15 hrs after removing doxycycline, CASPROTAC 6 was added for 24 hrs in a dose manner. The protein level of dCas9-APEX2 was monitored by Western blotting. B . Quantification of the intensity of the staining from A. Anti-Flag antibody was used to detect the level of dCas9-APEX-Flag proteins. Anti-β-actin was used as the loading control. C . The 293T-nCas9-PE2 bulk cells were pretreated with doxycycline (500 ng/mL) for 24 h, then removing doxycycline, CASPROTAC 6 was added for 24 hrs. The protein level of nCas9-PE2 was monitored by Western blotting. D . Quantification of the intensity of the staining from C. Anti-Cas9 antibody was used to detect the level of dCas9-APEX-Flag proteins. Anti-β-actin was used as the loading control. E . <t>293T-nCas9-BE3RA</t> bulk cells were pretreated with doxycycline (500 ng/mL) for 24 h. Then, after removing doxycycline, CASPROTAC 6 was added for another 24 hrs. The protein level of nCas9-BE3RA was monitored by Western blotting. F . Quantification of the intensity of the staining from E. Anti-Cas9 antibody was used to detect the level of dCas9-APEX-Flag proteins. Anti-β-actin was used as the loading control. Bars show mean value□±□s.e.m. and significance was calculated using Student’s t-test (n = 2 or 3). *p < 0.05, **p < 0.005, and ***p < 0.0001 (versus the control). G . CASPROTAC 6 reduced CRISPR editing efficiency. FANCF-gRNA and SpCas9 protein were mixed at a 1:1 molar ratio (20 pmol SpCas9+ 20 pmol FANCF-gRNA for 1 million cells) and incubated at room temperature for 20 min to allow the formation of the CRISPR ribonucleoprotein complexes. 293T cells were electroporated with FANCF-RNP. Six hours after electroporation, cells were incubated with CASPROTAC 6 for 24 hrs. CRISPR editing efficiency was measured by amplicon sequencing. H . The reduction of CRISPR/SpCas9-mediated editing based on the amplicon sequencing results. I . Batch output mode comparing CRISPR editing of control and CASPROTAC 6-treated cells. Each column represents the base composition of a single nucleotide at the FANCF site 2 locus. The percentage of each base or indel at each nucleotide is shown as a proportion of each row (n=1). *p < 0.05, **p < 0.005, and ***p < 0.0001 (versus the control).
    Plenti Tre3g Be3ra Pgk Puro, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 2 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/plenti tre3g be3ra pgk puro/product/Addgene inc
    Average 93 stars, based on 2 article reviews
    plenti tre3g be3ra pgk puro - by Bioz Stars, 2026-05
    93/100 stars

    Images

    1) Product Images from "PROTAC molecule-mediated SpCas9 protein degradation for precise genome editing"

    Article Title: PROTAC molecule-mediated SpCas9 protein degradation for precise genome editing

    Journal: bioRxiv

    doi: 10.1101/2025.01.07.631496

    A .Optimized CASPROTAC 6 degraded dCas9 proteins. 293T-Tet-On 3G cells with stable integration of dCas9-APEX2 were pretreated with doxycycline (500 ng/mL) for 9 h to the simultaneous expression of Cas9-APEX2 protein complex, 15 hrs after removing doxycycline, CASPROTAC 6 was added for 24 hrs in a dose manner. The protein level of dCas9-APEX2 was monitored by Western blotting. B . Quantification of the intensity of the staining from A. Anti-Flag antibody was used to detect the level of dCas9-APEX-Flag proteins. Anti-β-actin was used as the loading control. C . The 293T-nCas9-PE2 bulk cells were pretreated with doxycycline (500 ng/mL) for 24 h, then removing doxycycline, CASPROTAC 6 was added for 24 hrs. The protein level of nCas9-PE2 was monitored by Western blotting. D . Quantification of the intensity of the staining from C. Anti-Cas9 antibody was used to detect the level of dCas9-APEX-Flag proteins. Anti-β-actin was used as the loading control. E . 293T-nCas9-BE3RA bulk cells were pretreated with doxycycline (500 ng/mL) for 24 h. Then, after removing doxycycline, CASPROTAC 6 was added for another 24 hrs. The protein level of nCas9-BE3RA was monitored by Western blotting. F . Quantification of the intensity of the staining from E. Anti-Cas9 antibody was used to detect the level of dCas9-APEX-Flag proteins. Anti-β-actin was used as the loading control. Bars show mean value□±□s.e.m. and significance was calculated using Student’s t-test (n = 2 or 3). *p < 0.05, **p < 0.005, and ***p < 0.0001 (versus the control). G . CASPROTAC 6 reduced CRISPR editing efficiency. FANCF-gRNA and SpCas9 protein were mixed at a 1:1 molar ratio (20 pmol SpCas9+ 20 pmol FANCF-gRNA for 1 million cells) and incubated at room temperature for 20 min to allow the formation of the CRISPR ribonucleoprotein complexes. 293T cells were electroporated with FANCF-RNP. Six hours after electroporation, cells were incubated with CASPROTAC 6 for 24 hrs. CRISPR editing efficiency was measured by amplicon sequencing. H . The reduction of CRISPR/SpCas9-mediated editing based on the amplicon sequencing results. I . Batch output mode comparing CRISPR editing of control and CASPROTAC 6-treated cells. Each column represents the base composition of a single nucleotide at the FANCF site 2 locus. The percentage of each base or indel at each nucleotide is shown as a proportion of each row (n=1). *p < 0.05, **p < 0.005, and ***p < 0.0001 (versus the control).
    Figure Legend Snippet: A .Optimized CASPROTAC 6 degraded dCas9 proteins. 293T-Tet-On 3G cells with stable integration of dCas9-APEX2 were pretreated with doxycycline (500 ng/mL) for 9 h to the simultaneous expression of Cas9-APEX2 protein complex, 15 hrs after removing doxycycline, CASPROTAC 6 was added for 24 hrs in a dose manner. The protein level of dCas9-APEX2 was monitored by Western blotting. B . Quantification of the intensity of the staining from A. Anti-Flag antibody was used to detect the level of dCas9-APEX-Flag proteins. Anti-β-actin was used as the loading control. C . The 293T-nCas9-PE2 bulk cells were pretreated with doxycycline (500 ng/mL) for 24 h, then removing doxycycline, CASPROTAC 6 was added for 24 hrs. The protein level of nCas9-PE2 was monitored by Western blotting. D . Quantification of the intensity of the staining from C. Anti-Cas9 antibody was used to detect the level of dCas9-APEX-Flag proteins. Anti-β-actin was used as the loading control. E . 293T-nCas9-BE3RA bulk cells were pretreated with doxycycline (500 ng/mL) for 24 h. Then, after removing doxycycline, CASPROTAC 6 was added for another 24 hrs. The protein level of nCas9-BE3RA was monitored by Western blotting. F . Quantification of the intensity of the staining from E. Anti-Cas9 antibody was used to detect the level of dCas9-APEX-Flag proteins. Anti-β-actin was used as the loading control. Bars show mean value□±□s.e.m. and significance was calculated using Student’s t-test (n = 2 or 3). *p < 0.05, **p < 0.005, and ***p < 0.0001 (versus the control). G . CASPROTAC 6 reduced CRISPR editing efficiency. FANCF-gRNA and SpCas9 protein were mixed at a 1:1 molar ratio (20 pmol SpCas9+ 20 pmol FANCF-gRNA for 1 million cells) and incubated at room temperature for 20 min to allow the formation of the CRISPR ribonucleoprotein complexes. 293T cells were electroporated with FANCF-RNP. Six hours after electroporation, cells were incubated with CASPROTAC 6 for 24 hrs. CRISPR editing efficiency was measured by amplicon sequencing. H . The reduction of CRISPR/SpCas9-mediated editing based on the amplicon sequencing results. I . Batch output mode comparing CRISPR editing of control and CASPROTAC 6-treated cells. Each column represents the base composition of a single nucleotide at the FANCF site 2 locus. The percentage of each base or indel at each nucleotide is shown as a proportion of each row (n=1). *p < 0.05, **p < 0.005, and ***p < 0.0001 (versus the control).

    Techniques Used: Expressing, Western Blot, Staining, Control, CRISPR, Incubation, Electroporation, Amplification, Sequencing



    Similar Products

    plenti tre3g be3ra pgk puro  (Addgene inc)
    93
    Addgene inc plenti tre3g be3ra pgk puro
    A .Optimized CASPROTAC 6 degraded dCas9 proteins. 293T-Tet-On 3G cells with stable integration of dCas9-APEX2 were pretreated with doxycycline (500 ng/mL) for 9 h to the simultaneous expression of Cas9-APEX2 protein complex, 15 hrs after removing doxycycline, CASPROTAC 6 was added for 24 hrs in a dose manner. The protein level of dCas9-APEX2 was monitored by Western blotting. B . Quantification of the intensity of the staining from A. Anti-Flag antibody was used to detect the level of dCas9-APEX-Flag proteins. Anti-β-actin was used as the loading control. C . The 293T-nCas9-PE2 bulk cells were pretreated with doxycycline (500 ng/mL) for 24 h, then removing doxycycline, CASPROTAC 6 was added for 24 hrs. The protein level of nCas9-PE2 was monitored by Western blotting. D . Quantification of the intensity of the staining from C. Anti-Cas9 antibody was used to detect the level of dCas9-APEX-Flag proteins. Anti-β-actin was used as the loading control. E . <t>293T-nCas9-BE3RA</t> bulk cells were pretreated with doxycycline (500 ng/mL) for 24 h. Then, after removing doxycycline, CASPROTAC 6 was added for another 24 hrs. The protein level of nCas9-BE3RA was monitored by Western blotting. F . Quantification of the intensity of the staining from E. Anti-Cas9 antibody was used to detect the level of dCas9-APEX-Flag proteins. Anti-β-actin was used as the loading control. Bars show mean value□±□s.e.m. and significance was calculated using Student’s t-test (n = 2 or 3). *p < 0.05, **p < 0.005, and ***p < 0.0001 (versus the control). G . CASPROTAC 6 reduced CRISPR editing efficiency. FANCF-gRNA and SpCas9 protein were mixed at a 1:1 molar ratio (20 pmol SpCas9+ 20 pmol FANCF-gRNA for 1 million cells) and incubated at room temperature for 20 min to allow the formation of the CRISPR ribonucleoprotein complexes. 293T cells were electroporated with FANCF-RNP. Six hours after electroporation, cells were incubated with CASPROTAC 6 for 24 hrs. CRISPR editing efficiency was measured by amplicon sequencing. H . The reduction of CRISPR/SpCas9-mediated editing based on the amplicon sequencing results. I . Batch output mode comparing CRISPR editing of control and CASPROTAC 6-treated cells. Each column represents the base composition of a single nucleotide at the FANCF site 2 locus. The percentage of each base or indel at each nucleotide is shown as a proportion of each row (n=1). *p < 0.05, **p < 0.005, and ***p < 0.0001 (versus the control).
    Plenti Tre3g Be3ra Pgk Puro, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/plenti tre3g be3ra pgk puro/product/Addgene inc
    Average 93 stars, based on 1 article reviews
    plenti tre3g be3ra pgk puro - by Bioz Stars, 2026-05
    93/100 stars
    		  Buy from Supplier
    be3ra  (Addgene inc)
    92
    Addgene inc be3ra
    A .Optimized CASPROTAC 6 degraded dCas9 proteins. 293T-Tet-On 3G cells with stable integration of dCas9-APEX2 were pretreated with doxycycline (500 ng/mL) for 9 h to the simultaneous expression of Cas9-APEX2 protein complex, 15 hrs after removing doxycycline, CASPROTAC 6 was added for 24 hrs in a dose manner. The protein level of dCas9-APEX2 was monitored by Western blotting. B . Quantification of the intensity of the staining from A. Anti-Flag antibody was used to detect the level of dCas9-APEX-Flag proteins. Anti-β-actin was used as the loading control. C . The 293T-nCas9-PE2 bulk cells were pretreated with doxycycline (500 ng/mL) for 24 h, then removing doxycycline, CASPROTAC 6 was added for 24 hrs. The protein level of nCas9-PE2 was monitored by Western blotting. D . Quantification of the intensity of the staining from C. Anti-Cas9 antibody was used to detect the level of dCas9-APEX-Flag proteins. Anti-β-actin was used as the loading control. E . <t>293T-nCas9-BE3RA</t> bulk cells were pretreated with doxycycline (500 ng/mL) for 24 h. Then, after removing doxycycline, CASPROTAC 6 was added for another 24 hrs. The protein level of nCas9-BE3RA was monitored by Western blotting. F . Quantification of the intensity of the staining from E. Anti-Cas9 antibody was used to detect the level of dCas9-APEX-Flag proteins. Anti-β-actin was used as the loading control. Bars show mean value□±□s.e.m. and significance was calculated using Student’s t-test (n = 2 or 3). *p < 0.05, **p < 0.005, and ***p < 0.0001 (versus the control). G . CASPROTAC 6 reduced CRISPR editing efficiency. FANCF-gRNA and SpCas9 protein were mixed at a 1:1 molar ratio (20 pmol SpCas9+ 20 pmol FANCF-gRNA for 1 million cells) and incubated at room temperature for 20 min to allow the formation of the CRISPR ribonucleoprotein complexes. 293T cells were electroporated with FANCF-RNP. Six hours after electroporation, cells were incubated with CASPROTAC 6 for 24 hrs. CRISPR editing efficiency was measured by amplicon sequencing. H . The reduction of CRISPR/SpCas9-mediated editing based on the amplicon sequencing results. I . Batch output mode comparing CRISPR editing of control and CASPROTAC 6-treated cells. Each column represents the base composition of a single nucleotide at the FANCF site 2 locus. The percentage of each base or indel at each nucleotide is shown as a proportion of each row (n=1). *p < 0.05, **p < 0.005, and ***p < 0.0001 (versus the control).
    Be3ra, supplied by Addgene inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/be3ra/product/Addgene inc
    Average 92 stars, based on 1 article reviews
    be3ra - by Bioz Stars, 2026-05
    92/100 stars
    		  Buy from Supplier
    plenti be3ra p2a gfp pgk puro  (Addgene inc)
    92
    Addgene inc plenti be3ra p2a gfp pgk puro
    A .Optimized CASPROTAC 6 degraded dCas9 proteins. 293T-Tet-On 3G cells with stable integration of dCas9-APEX2 were pretreated with doxycycline (500 ng/mL) for 9 h to the simultaneous expression of Cas9-APEX2 protein complex, 15 hrs after removing doxycycline, CASPROTAC 6 was added for 24 hrs in a dose manner. The protein level of dCas9-APEX2 was monitored by Western blotting. B . Quantification of the intensity of the staining from A. Anti-Flag antibody was used to detect the level of dCas9-APEX-Flag proteins. Anti-β-actin was used as the loading control. C . The 293T-nCas9-PE2 bulk cells were pretreated with doxycycline (500 ng/mL) for 24 h, then removing doxycycline, CASPROTAC 6 was added for 24 hrs. The protein level of nCas9-PE2 was monitored by Western blotting. D . Quantification of the intensity of the staining from C. Anti-Cas9 antibody was used to detect the level of dCas9-APEX-Flag proteins. Anti-β-actin was used as the loading control. E . <t>293T-nCas9-BE3RA</t> bulk cells were pretreated with doxycycline (500 ng/mL) for 24 h. Then, after removing doxycycline, CASPROTAC 6 was added for another 24 hrs. The protein level of nCas9-BE3RA was monitored by Western blotting. F . Quantification of the intensity of the staining from E. Anti-Cas9 antibody was used to detect the level of dCas9-APEX-Flag proteins. Anti-β-actin was used as the loading control. Bars show mean value□±□s.e.m. and significance was calculated using Student’s t-test (n = 2 or 3). *p < 0.05, **p < 0.005, and ***p < 0.0001 (versus the control). G . CASPROTAC 6 reduced CRISPR editing efficiency. FANCF-gRNA and SpCas9 protein were mixed at a 1:1 molar ratio (20 pmol SpCas9+ 20 pmol FANCF-gRNA for 1 million cells) and incubated at room temperature for 20 min to allow the formation of the CRISPR ribonucleoprotein complexes. 293T cells were electroporated with FANCF-RNP. Six hours after electroporation, cells were incubated with CASPROTAC 6 for 24 hrs. CRISPR editing efficiency was measured by amplicon sequencing. H . The reduction of CRISPR/SpCas9-mediated editing based on the amplicon sequencing results. I . Batch output mode comparing CRISPR editing of control and CASPROTAC 6-treated cells. Each column represents the base composition of a single nucleotide at the FANCF site 2 locus. The percentage of each base or indel at each nucleotide is shown as a proportion of each row (n=1). *p < 0.05, **p < 0.005, and ***p < 0.0001 (versus the control).
    Plenti Be3ra P2a Gfp Pgk Puro, supplied by Addgene inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/plenti be3ra p2a gfp pgk puro/product/Addgene inc
    Average 92 stars, based on 1 article reviews
    plenti be3ra p2a gfp pgk puro - by Bioz Stars, 2026-05
    92/100 stars
    		  Buy from Supplier

    Image Search Results


    A .Optimized CASPROTAC 6 degraded dCas9 proteins. 293T-Tet-On 3G cells with stable integration of dCas9-APEX2 were pretreated with doxycycline (500 ng/mL) for 9 h to the simultaneous expression of Cas9-APEX2 protein complex, 15 hrs after removing doxycycline, CASPROTAC 6 was added for 24 hrs in a dose manner. The protein level of dCas9-APEX2 was monitored by Western blotting. B . Quantification of the intensity of the staining from A. Anti-Flag antibody was used to detect the level of dCas9-APEX-Flag proteins. Anti-β-actin was used as the loading control. C . The 293T-nCas9-PE2 bulk cells were pretreated with doxycycline (500 ng/mL) for 24 h, then removing doxycycline, CASPROTAC 6 was added for 24 hrs. The protein level of nCas9-PE2 was monitored by Western blotting. D . Quantification of the intensity of the staining from C. Anti-Cas9 antibody was used to detect the level of dCas9-APEX-Flag proteins. Anti-β-actin was used as the loading control. E . 293T-nCas9-BE3RA bulk cells were pretreated with doxycycline (500 ng/mL) for 24 h. Then, after removing doxycycline, CASPROTAC 6 was added for another 24 hrs. The protein level of nCas9-BE3RA was monitored by Western blotting. F . Quantification of the intensity of the staining from E. Anti-Cas9 antibody was used to detect the level of dCas9-APEX-Flag proteins. Anti-β-actin was used as the loading control. Bars show mean value□±□s.e.m. and significance was calculated using Student’s t-test (n = 2 or 3). *p < 0.05, **p < 0.005, and ***p < 0.0001 (versus the control). G . CASPROTAC 6 reduced CRISPR editing efficiency. FANCF-gRNA and SpCas9 protein were mixed at a 1:1 molar ratio (20 pmol SpCas9+ 20 pmol FANCF-gRNA for 1 million cells) and incubated at room temperature for 20 min to allow the formation of the CRISPR ribonucleoprotein complexes. 293T cells were electroporated with FANCF-RNP. Six hours after electroporation, cells were incubated with CASPROTAC 6 for 24 hrs. CRISPR editing efficiency was measured by amplicon sequencing. H . The reduction of CRISPR/SpCas9-mediated editing based on the amplicon sequencing results. I . Batch output mode comparing CRISPR editing of control and CASPROTAC 6-treated cells. Each column represents the base composition of a single nucleotide at the FANCF site 2 locus. The percentage of each base or indel at each nucleotide is shown as a proportion of each row (n=1). *p < 0.05, **p < 0.005, and ***p < 0.0001 (versus the control).

    Journal: bioRxiv

    Article Title: PROTAC molecule-mediated SpCas9 protein degradation for precise genome editing

    doi: 10.1101/2025.01.07.631496

    Figure Lengend Snippet: A .Optimized CASPROTAC 6 degraded dCas9 proteins. 293T-Tet-On 3G cells with stable integration of dCas9-APEX2 were pretreated with doxycycline (500 ng/mL) for 9 h to the simultaneous expression of Cas9-APEX2 protein complex, 15 hrs after removing doxycycline, CASPROTAC 6 was added for 24 hrs in a dose manner. The protein level of dCas9-APEX2 was monitored by Western blotting. B . Quantification of the intensity of the staining from A. Anti-Flag antibody was used to detect the level of dCas9-APEX-Flag proteins. Anti-β-actin was used as the loading control. C . The 293T-nCas9-PE2 bulk cells were pretreated with doxycycline (500 ng/mL) for 24 h, then removing doxycycline, CASPROTAC 6 was added for 24 hrs. The protein level of nCas9-PE2 was monitored by Western blotting. D . Quantification of the intensity of the staining from C. Anti-Cas9 antibody was used to detect the level of dCas9-APEX-Flag proteins. Anti-β-actin was used as the loading control. E . 293T-nCas9-BE3RA bulk cells were pretreated with doxycycline (500 ng/mL) for 24 h. Then, after removing doxycycline, CASPROTAC 6 was added for another 24 hrs. The protein level of nCas9-BE3RA was monitored by Western blotting. F . Quantification of the intensity of the staining from E. Anti-Cas9 antibody was used to detect the level of dCas9-APEX-Flag proteins. Anti-β-actin was used as the loading control. Bars show mean value□±□s.e.m. and significance was calculated using Student’s t-test (n = 2 or 3). *p < 0.05, **p < 0.005, and ***p < 0.0001 (versus the control). G . CASPROTAC 6 reduced CRISPR editing efficiency. FANCF-gRNA and SpCas9 protein were mixed at a 1:1 molar ratio (20 pmol SpCas9+ 20 pmol FANCF-gRNA for 1 million cells) and incubated at room temperature for 20 min to allow the formation of the CRISPR ribonucleoprotein complexes. 293T cells were electroporated with FANCF-RNP. Six hours after electroporation, cells were incubated with CASPROTAC 6 for 24 hrs. CRISPR editing efficiency was measured by amplicon sequencing. H . The reduction of CRISPR/SpCas9-mediated editing based on the amplicon sequencing results. I . Batch output mode comparing CRISPR editing of control and CASPROTAC 6-treated cells. Each column represents the base composition of a single nucleotide at the FANCF site 2 locus. The percentage of each base or indel at each nucleotide is shown as a proportion of each row (n=1). *p < 0.05, **p < 0.005, and ***p < 0.0001 (versus the control).

    Article Snippet: For generating the pLenti-TRE3G-BE3RA-PGK-Puro (Addgene 110846) virus, the 293T cells were grown in 6 well plates.

    Techniques: Expressing, Western Blot, Staining, Control, CRISPR, Incubation, Electroporation, Amplification, Sequencing